浙江永太科技股份有限公司 2017 年第三季度报告正文 证券代码：002326 证券简称：永太科技 公告编号：2017-74 浙江永太科技股份有限公司 2017 年第三季度报告正文 1 浙江永太科技股份有限公司 2017 年第三季度报告正文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人王莺妹、主管会计工作负责人陈丽洁及会计机构负责人(会计主 管人员)倪晓燕声明：保证季度报告中财务报表的真实、准确、完整。 2 浙江永太科技股份有限公司 2017 年第三季度报告正文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 项目界定为经常性损益的项目的情形。 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末 | | --- | --- | --- | --- | --- | | | | | | 增减 | | 总资产（元） | 5,977,255,121.90 | | 4 ...

浙江永太科技股份有限公司 2017 年半年度报告全文 浙江永太科技股份有限公司 2017 年半年度报告 公司负责人王莺妹、主管会计工作负责人陈丽洁及会计机构负责人(会计主 管人员)倪晓燕声明：保证本半年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 股票代码：002326 公司简称：永太科技 报告日期：2017 年 8 月 18 日 1 浙江永太科技股份有限公司 2017 年半年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的 真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和 连带的法律责任。 本半年度报告中涉及未来计划等前瞻性陈述属于计划性事项，不构成公司 对投资者的实质承诺，投资者及相关人士均应对此保持足够的风险认识，并且 应当理解计划、预测与承诺之间的差异。 公司在本报告第四节"经营情况讨论与分析"中"十、公司面临的风险和应对 措施"描述了公司经营中可能面临的风险，敬请投资者关注相关内容，注意投资 风险。 公司计划不派发现金红利，不送红股，不以公积金转增股本。 2 | 目录 | | --- | ...

公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人王莺妹、主管会计工作负责人陈丽洁及会计机构负责人(会计主 管人员)倪晓燕声明：保证季度报告中财务报表的真实、准确、完整。 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否因会计政策变更及会计差错更正等追溯调整或重述以前年度会计数据 浙江永太科技股份有限公司 2017 年第一季度报告正文 证券代码：002326 证券简称：永太科技 公告编号：2017-25 浙江永太科技股份有限公司 2017 年第一季度报告正文 第一节 重要提示 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增 | | --- | --- | --- | --- | | | | | 减 | | 营业收入（元） | 526,825,475.21 | 416,706,400.72 | 26.43% | | 归属于上市公司股东的净利润（元） | 164,292,701.57 | 38,146,661.11 | ...

浙江永太科技股份有限公司 2016 年年度报告 股票代码：002326 公司简称：永太科技 报告日期：2017 年 4 月 11 日 浙江永太科技股份有限公司 2016 年年度报告全文 第一节 重要提示、目录和释义 本公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的 真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和 连带的法律责任。 公司负责人王莺妹、主管会计工作负责人陈丽洁及会计机构负责人(会计主 管人员)倪晓燕声明：保证年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 公司在本报告第四节"经营情况讨论与分析"中"公司未来发展的展望"部 分，具体描述了公司经营过程中可能存在的风险及应对措施，敬请投资者关注 相关内容。 公司计划不派发现金红利，不送红股，不以公积金转增股本。 | 第一节 重要提示、目录和释义 2 | | --- | | 第二节 公司简介和主要财务指标 4 | | 第三节 公司业务概要 8 | | 第四节 经营情况讨论与分析 10 | | 第五节 重要事项 28 | | 第六节 股份变动及股东情况 39 | | 第七节 优先股相 ...

浙江永太科技股份有限公司 2016 年第三季度报告正文 证券代码：002326 证券简称：永太科技 公告编号：2016-107 浙江永太科技股份有限公司 2016 年第三季度报告正文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人王莺妹、主管会计工作负责人陈丽洁及会计机构负责人(会计主 管人员)倪晓燕声明：保证季度报告中财务报表的真实、准确、完整。 第二节 主要财务数据及股东变化 一、主要会计数据和财务指标 公司是否因会计政策变更及会计差错更正等追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末增 | | --- | --- | --- | --- | --- | | | | | | 减 | | 总资产（元） | 3,994,563,322.88 | | 3,437,064,233.35 | 16.22% | | 归属于上市公司股东的净资产 （元） | 1,955,609 ...

浙江永太科技股份有限公司 2016 年第三季度报告正文 证券代码：002326 证券简称：永太科技 公告编号：2016-107 浙江永太科技股份有限公司 2016 年第三季度报告正文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人王莺妹、主管会计工作负责人陈丽洁及会计机构负责人(会计主 管人员)倪晓燕声明：保证季度报告中财务报表的真实、准确、完整。 第二节 主要财务数据及股东变化 一、主要会计数据和财务指标 公司是否因会计政策变更及会计差错更正等追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末增 | | --- | --- | --- | --- | --- | | | | | | 减 | | 总资产（元） | 3,994,563,322.88 | | 3,437,064,233.35 | 16.22% | | 归属于上市公司股东的净资产 （元） | 1,955,609 ...

Financial Performance - The company's operating revenue for the first half of 2016 was ¥931,220,549.22, representing a 28.70% increase compared to ¥723,552,528.35 in the same period last year[23]. - The net profit attributable to shareholders of the listed company was ¥110,881,075.92, a slight increase of 0.20% from ¥110,661,243.73 in the previous year[23]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥103,733,391.97, up 5.72% from ¥98,119,654.74 year-on-year[23]. - The net cash flow from operating activities increased significantly by 246.76% to ¥38,243,494.78, compared to ¥11,028,770.22 in the same period last year[23]. - Total assets at the end of the reporting period reached ¥3,866,788,709.82, a 12.50% increase from ¥3,437,064,233.35 at the end of the previous year[23]. - The net assets attributable to shareholders of the listed company were ¥1,944,902,262.43, reflecting a 3.89% increase from ¥1,872,125,239.05 at the end of the previous year[23]. - The basic earnings per share remained stable at ¥0.139, unchanged from the previous year[23]. - The diluted earnings per share also remained at ¥0.139, consistent with the previous year[23]. - The weighted average return on net assets decreased to 5.76%, down 0.60% from 6.36% in the previous year[23]. Operating Costs and Expenses - Operating costs rose to CNY 689.75 million, reflecting a 33.11% increase compared to the previous year, primarily due to changes in the scope of consolidation[34]. - Research and development expenses increased significantly by 92.72% to CNY 41.87 million, indicating a strong focus on innovation and new product development[34]. - Sales expenses surged by 124.17% to CNY 17.86 million, attributed to changes in the consolidation scope[34]. Strategic Initiatives - The company made strategic acquisitions, including the purchase of Zhuoyue Precision and investments in healthcare management platforms, to enhance its market position[31]. - The company initiated the establishment of a new high-tech subsidiary to enter the lithium battery sector, focusing on fluorinated electrolytes[31]. - The company is actively pursuing market expansion and strategic investments to strengthen its pharmaceutical segment and overall business growth[31]. Cash Flow and Financing Activities - Cash and cash equivalents decreased by 110.61% to CNY -49.61 million, mainly due to reduced net cash flow from financing activities[35]. - The company reported a significant increase in operating cash flow, with a net cash flow from operating activities of CNY 38.24 million, up 246.76% year-on-year[34]. - The company raised a net amount of RMB 593,527,440.29 through a private placement of shares during the reporting period[57]. - The company plans to use RMB 290 million of idle raised funds to temporarily supplement working capital, with a usage period not exceeding 12 months[58]. Shareholder and Governance Information - The company has a governance structure that complies with relevant laws and regulations, ensuring the protection of minority shareholders' rights[75]. - The board of directors consists of 9 members, including 3 independent directors, ensuring a balanced governance framework[78]. - The company is committed to transparent information disclosure, ensuring all shareholders have equal access to information[81]. - The management team is held accountable through a clear performance evaluation and incentive mechanism[83]. Investment and Acquisitions - The company completed the acquisition of Shanghai Keling Medical Technology Co., Ltd. with a 19% equity stake for 21.59 million yuan, finalized on May 24, 2016[87]. - The company acquired 100% equity of Zhejiang Excellent Fine Chemicals Co., Ltd. for a transaction price of 145 million yuan, with a payment of 60 million yuan made as of June 30, 2016[87]. - The company invested 10.5% in Shenzhen Meisai Technology Co., Ltd. for 105 million yuan, with the payment completed as of June 30, 2016[87]. Financial Stability and Compliance - The company has confirmed its ability to continue as a going concern for at least 12 months from the reporting date[186]. - The financial statements prepared by the company comply with the requirements of the accounting standards, reflecting the company's financial position, operating results, and cash flows accurately[188]. - The company has not encountered any major changes in the feasibility of its investment projects during the reporting period[61]. Share Capital and Dividends - The company plans not to distribute cash dividends or issue bonus shares for this reporting period[7]. - The company implemented a cash dividend of 0.60 yuan per 10 shares for the 2015 fiscal year, totaling a distribution based on 798,610,481 shares[70]. - The company has committed to distributing no less than 35% of the average distributable profit from 2013 to 2015 in cash, contingent on profitability and cash flow sufficiency for sustainable operations[113].

Financial Performance - The company's operating revenue for Q1 2016 was ¥416,706,400.72, representing a 51.46% increase compared to ¥275,124,865.03 in the same period last year[5] - The net profit attributable to shareholders was ¥38,146,661.11, showing a slight decrease of 0.15% from ¥38,205,194.25 year-on-year[5] - The basic earnings per share for the period was ¥0.0478, a decrease of 0.42% from ¥0.0480 in the same period last year[5] - The weighted average return on equity was 2.02%, down from 2.24% in the previous year[5] - The net profit attributable to shareholders for the first half of 2016 is expected to increase by 0.00% to 30.00% compared to the same period in 2015, with an estimated range of 11,066.12 to 14,385.96 thousand yuan[16] Cash Flow - The net cash flow from operating activities increased significantly by 119.46%, reaching ¥84,151,680.23 compared to ¥38,344,529.96 in the previous year[5] - Net cash flow from operating activities increased by 119.46% year-on-year, primarily due to an increase in received payments[13] - The net cash flow from investment activities surged by 549.85% compared to the previous period, mainly due to increased payments for equity transfer and equipment purchases[13] Assets and Shareholders - Total assets at the end of the reporting period were ¥3,555,635,286.36, up 3.45% from ¥3,437,064,233.35 at the end of the previous year[6] - The net assets attributable to shareholders increased by 2.05%, amounting to ¥1,910,465,290.59 compared to ¥1,872,125,239.05 at the end of the last year[6] - The total number of shareholders at the end of the reporting period was 93,174[9] - The largest shareholder, Wang Yingmei, holds 24.13% of the shares, with 145,151,970 shares pledged[9] - The company did not engage in any repurchase transactions among the top 10 shareholders during the reporting period[11] Operational Metrics - Accounts receivable increased by 81.92% compared to the previous period, mainly due to an increase in received bills during the reporting period[13] - Operating revenue grew by 51.46% year-on-year, attributed to expanded production and sales scale as well as an increase in the scope of consolidation[13] - Operating costs rose by 59.89% compared to the previous period, driven by the same factors of expanded production and sales scale[13] - Sales expenses increased by 248.37% year-on-year, reflecting the expanded production and sales scale[13] Other Financial Changes - The fair value change income rose by 385.6% compared to the previous period, mainly due to foreign exchange rate fluctuations[13] - Long-term borrowings decreased by 45.71% compared to the previous period, primarily due to repayments of bank loans[13] - Special reserves increased by 518.7% year-on-year, mainly due to a reduction in safety production expenses[13]

Financial Performance - The company's operating revenue for 2015 was ¥1,542,012,579.18, representing a 45.27% increase compared to ¥1,061,449,342.59 in 2014[6]. - The net profit attributable to shareholders for 2015 was ¥144,265,024.50, a 73.10% increase from ¥83,342,432.30 in 2014[6]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥141,585,672.82, up 94.09% from ¥72,948,958.69 in 2014[6]. - The company's total assets at the end of 2015 were ¥3,437,064,233.35, a 36.49% increase from ¥2,518,185,780.75 at the end of 2014[18]. - The net assets attributable to shareholders at the end of 2015 were ¥1,872,125,239.05, reflecting a 10.83% increase from ¥1,689,114,056.92 at the end of 2014[18]. - The basic earnings per share for 2015 was ¥0.18, a 50.00% increase from ¥0.12 in 2014[6]. - The net cash flow from operating activities for 2015 was ¥66,258,151.20, a decrease of 60.24% compared to ¥166,637,109.98 in 2014[6]. - The company achieved a total operating revenue of ¥1,542,012,579.18 in 2015, representing a year-on-year increase of 45.27% compared to ¥1,061,449,342.59 in 2014[48]. - The total revenue for 2015 was 827,037,827.34 CNY, an increase of 11.25% compared to 743,619,342.89 CNY in 2014[56]. Dividends and Profit Distribution - The company proposed a cash dividend of 0.6 CNY per 10 shares, totaling 47,916,628.86 CNY for the year 2015, which represents 33.21% of the net profit attributable to ordinary shareholders[104]. - The net profit attributable to the company's shareholders for 2015 was 144,265,024.50 CNY, with a cash dividend payout ratio of 33.21%[102]. - The total distributable profit for 2015 was 413,588,911.50 CNY, with cash dividends accounting for 100% of the profit distribution[103]. - The company has a policy to distribute at least 20% of profits as cash dividends during its growth phase, provided cash flow supports ongoing operations[103]. - The company has committed to distributing no less than 35% of the average annual distributable profit over the last three years in cash dividends[104]. Business Operations and Strategy - The company has undergone a business scope change in May 2015, expanding into the sales of pesticides and organic intermediates[16]. - The company operates multiple subsidiaries, including Zhejiang Yongtai Pharmaceutical Co., Ltd. and Jiangsu Qichuang Chemical Co., Ltd.[9]. - The company is focused on the development of liquid crystal chemicals and pharmaceutical chemicals, which are essential for various applications[9]. - The company operates in a stable market with rigid demand for fine fluorochemical products, indicating potential for future growth[27]. - The company is actively developing its pharmaceutical segment, with ongoing progress in internationalization and regulatory approvals for its products[43]. - The company aims to enhance its management level and ensure stable operations while continuing to improve safety and environmental standards[86]. - The company plans to increase R&D investment and innovate new products to maintain its leading position in the fluorinated fine chemicals market[87]. - The company will focus on optimizing its product structure and extending its industrial chain to enhance competitiveness in the pharmaceutical, agricultural, and electronic chemical sectors[84]. Risk Management - The company emphasizes the importance of risk management and has outlined potential risks and countermeasures in its future development outlook[5]. - The company recognizes the risk of economic uncertainty affecting sales due to its upstream raw material focus and plans to deepen customer relationships to mitigate this risk[93]. - The company is committed to complying with environmental regulations and expects increased environmental costs, which may impact performance but also create new market opportunities[95]. Research and Development - Research and development investment totaled CNY 7,404.07 million, reflecting an increase of 8.79% year-on-year[41]. - The company completed the development of 60 new products and achieved 18 pilot tests during the reporting period[41]. - The company's gross profit margin for LCD chemicals improved to 27.79% in 2015 from 24.71% in 2014, reflecting a year-on-year increase of 25.08%[55]. Corporate Governance - The company has a well-established corporate governance structure and ensures timely and accurate information disclosure to protect shareholder rights[137]. - The company has implemented a restricted stock incentive plan to enhance employee engagement and align interests between management and shareholders[138]. - The company adheres to legal compliance in its operations, ensuring fair dealings with suppliers and customers[139]. - The company has a structured approach to governance, with a focus on maintaining an independent board of directors[165][166]. Shareholder Information - The largest shareholder, Wang Yingmei, holds 24.13% of the shares, totaling 192,740,720 shares, with 145,151,970 shares pledged[151]. - The second-largest shareholder, He Renbao, holds 18.58% of the shares, totaling 148,400,000 shares, with 111,300,000 shares pledged[151]. - The company has not conducted any repurchase transactions among the top 10 shareholders during the reporting period[152]. - The controlling shareholders, Wang Yingmei and He Renbao, have not changed during the reporting period[154]. Employee and Management - The total number of employees in the company is 1,707, with 1,054 in the parent company and 653 in major subsidiaries[181]. - The company has optimized employee compensation in 2015, enhancing its competitiveness in the market[182]. - The company has established a comprehensive training system for employees, including various training forms such as onboarding and management training[183]. - The company follows a performance-based compensation structure for its directors and senior management, with annual performance evaluations conducted by the remuneration and assessment committee[176].

浙江永太科技股份有限公司 2015 年第三季度报告全文 浙江永太科技股份有限公司 2015 年第三季度报告 2015 年 10 月 27 日 1 浙江永太科技股份有限公司 2015 年第三季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人王莺妹、主管会计工作负责人陈丽洁及会计机构负责人(会计主 管人员)倪晓燕声明：保证季度报告中财务报表的真实、准确、完整。 2 浙江永太科技股份有限公司 2015 年第三季度报告全文 第二节 主要财务数据及股东变化 一、主要会计数据和财务指标 公司是否因会计政策变更及会计差错更正等追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末增减 | | --- | --- | --- | --- | --- | | 总资产（元） | 3,214,691,628.67 | 2,518,185,780.75 | | 27.66% | | 归属于 ...